Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

A new indole glycoside from Kitasatospora sp. MG372-hF19 carrying a 6-deoxy-α-l-talopyranose moiety

Abstract

Small cell lung cancer (SCLC) is a severe malignancy with early and widespread metastasis, and novel therapeutic drugs are needed. To identify cytotoxic natural compounds against SCLC, we screened libraries of microbial fermentation broths using several lung cancer cell lines. We found that the actinomycete strain MG372-hF19 produces a compound that has not been isolated from natural sources but previously chemically synthesized, 6-chloro-1H-indole-3-carboxaldehyde (1), and an entirely new compound, named 6-deoxy-α-L-talopyranose 1-(6-chloro-1H-indole-3-carboxylate) (2), together with leptomycins. The molecular formulas of the compounds were established as C9H6ClNO and C15H16ClNO6, respectively, via high-resolution electrospray ionization mass spectrometry, and their structures were determined using detailed NMR. Absolute configurational analysis of the sugar unit of compound 2 revealed that the compound incorporates the rare deoxyhexose 6-deoxy-α-L-talopyranose. Both compounds exhibited weak growth-inhibiting activities against human lung cancer cell lines.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

References

  1. Oronsky B, Reid TR, Oronsky A, Carter CA. What’s new in SCLC? A review. Neoplasia 2017;19:842–7.

    Article  CAS  Google Scholar 

  2. Sakamoto S, et al. New metastatic model of human small-cell lung cancer by orthotopic transplantation in mice. Cancer Sci. 2015;106:367–74.

    Article  CAS  Google Scholar 

  3. Hamamoto T, et al. Leptomycins A and B, new antifungal antibiotics. I. Taxonomy of the producing strain and their fermentation, purification and characterization. J. Antibiot. 1983;36:639–45.

    Article  CAS  Google Scholar 

  4. Hamamoto T, et al. Leptomycins A and B, new antifungal antibiotics. II. Structure elucidation. J. Antibiot. 1983;36:646–50.

    Article  CAS  Google Scholar 

  5. Sanghee L, Seung BP. An efficient one-step synthesis of heterobiaryl pyrazolo[3,4-b]pyridines via indole ring opening. Org. Lett. 2009;11:5214–7.

    Article  CAS  Google Scholar 

  6. Angeles M, et al. Intramolecular 1,8-hydrogen atom transfer. Stereoselectivity of the hexopyranos-5’-yl radical reactions in hexp-(1→4)-hexp disaccharide systems. J. Org. Chem. 2008;73:7710–20.

    Article  CAS  Google Scholar 

  7. Kato S, et al. Phenazoviridin, a novel free radical scavenger from Streptomyces sp. Taxonomy, fermentation, isolation, structure elucidation and biological propaties. J. Antibiot. 1993;46:1485–93.

    Article  CAS  Google Scholar 

  8. Yoon TM, et al. Talosins A and B: new isoflavonol glycosides with potent antifungal activity from Kitasatospora kifunensis MJM341. I. Taxonomy, fermentation, isolation, and biological activities. J. Antibiot. 2006;59:633–9.

    Article  CAS  Google Scholar 

  9. Son SK, et al. Polyketides and anthranilic acid possessing 6-deoxy-α-L-talopyranose from a Streptomyces Species. J. Nat. Prod. 2017;80:1378–86.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Ms Tamami Yoshida, Ms Satomi Unno, and Ms Rina Ando for their technical assistance. We also thank the members of the Institute of Microbial Chemistry, Numazu for helpful discussion. This work was supported in part by grants from JSPS KAKENHI Grant Number 17K08777. We thank Joe Barber, Jr., PhD, from Edanz Group (www.edanzediting.com/ac) for editing a draft of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shuichi Sakamoto.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kohda, Y., Sakamoto, S., Otsuka, Y. et al. A new indole glycoside from Kitasatospora sp. MG372-hF19 carrying a 6-deoxy-α-l-talopyranose moiety. J Antibiot 73, 167–170 (2020). https://doi.org/10.1038/s41429-019-0258-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41429-019-0258-9

This article is cited by

Search

Quick links